Blood-Based Circulating Tumor DNA for Early Detection of Colorectal Cancer: A Systematic Review and Meta-Analysis
Digestive Diseases · 30.03.2026 · 44 (3) · 280-297
DOI: 10.1159/000551806 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Digestive Diseases, online erschienen am 30.03.2026. Verfasst von Yashaswi Guntupalli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, India. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Circulating Tumor DNA, Early Detection of Cancer. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Circulating tumor DNA (ctDNA) assays are emerging as promising noninvasive tools for colorectal cancer (CRC) screening. This updated systematic review and meta-analysis evaluated the diagnostic accuracy of blood-based ctDNA assays for early CRC detection in asymptomatic adults.
Methods
We included prospective and cross-sectional diagnostic accuracy studies comparing ctDNA assays (mutation, methylation, or fragment-based) against colonoscopy or histopathology. Study-level 2 × 2 data were extracted to calculate sensitivity and specificity. Pooled estimates were derived using a Reitsma bivariate random-effects model. Secondary measures like diagnostic odds ratio (DOR), positive and negative likelihood ratios (PLR, NLR), positive predictive value (PPV), and negative predictive value (NPV) were synthesized on transformed scales and back-transformed for reporting. Subgroup analyses by assay type and meta-regression explored heterogeneity. Risk of bias was assessed with QUADAS-2 and certainty of evidence with GRADE.
Results
Ten studies met inclusion criteria, nine contributing to pooled estimates. The pooled sensitivity was 0.887 (95% CI, 0.848–0.920) and specificity 0.913 (95% CI, 0.898–0.928). A sensitivity analysis excluding studies with high risk of bias in patient selection yielded a comparable pooled sensitivity of 0.857 (95% CI, 0.794–0.904) and specificity of 0.900 (95% CI, 0.897–0.904). The SROC curve yielded an AUC of 0.97, indicating excellent discrimination. Secondary pooled metrics included a DOR of 83.9, PLR of 9.2, and NLR of 0.12. PPV was low (99%) at screening prevalences of 0.5–2%. Subgroup analyses by assay type revealed no significant differences in diagnostic accuracy.
Conclusion
Blood-based ctDNA assays show high pooled sensitivity, specificity, and discrimination for CRC detection, but limited predictive value at screening prevalence and study heterogeneity constrain clinical adoption. Large, standardized, population-based studies are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
- Department of Internal Medicine, One Brooklyn Health, Brooklyn, New York, USA.
- Department of Hospital Medicine, Cleveland Clinic, Cleveland, Ohio, USA, potlurv@ccf.org.
- Department of Clinical Medicine, School of Medicine, Xiamen University, Xiamen, China.
- Department of General Medicine, Meenakshi Medical College Hospital and Research Institute, Kanchipuram, India.
- Department of Internal Medicine, Allegheny College, Meadville, Pennsylvania, USA.
Zitieren
APA
Guntupalli, Y., Nimmagadda, R., Potluri, V., Majety, S. K., Mangalagiri, T., Yendluri, A., Changela, M., Kakarla, M., Oudit, O., & Hasan, M. (2026). Blood-Based Circulating Tumor DNA for Early Detection of Colorectal Cancer: A Systematic Review and Meta-Analysis. Digestive Diseases, 44(3), 280-297. https://doi.org/10.1159/000551806
Vancouver
Guntupalli Y, Nimmagadda R, Potluri V, Majety SK, Mangalagiri T, Yendluri A, et al. Blood-Based Circulating Tumor DNA for Early Detection of Colorectal Cancer: A Systematic Review and Meta-Analysis. Digestive Diseases. 2026;44(3):280-297. doi:10.1159/000551806
BibTeX
@article{Guntupalli2026,
author = {Guntupalli, Yashaswi and Nimmagadda, Rithish and Potluri, Vineeth and Majety, Sameer Kumar and Mangalagiri, Tejaswi and Yendluri, Ananya and Changela, Madhav and Kakarla, Meghana and Oudit, Omar and Hasan, Muhammad},
title = {Blood-Based Circulating Tumor DNA for Early Detection of Colorectal Cancer: A Systematic Review and Meta-Analysis},
journal = {Digestive Diseases},
year = {2026},
volume = {44},
number = {3},
pages = {280--297},
doi = {10.1159/000551806}
}
EUVIMED